Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile.
You can purchase shares of Pacific Biosciences (NASDAQ:PACB) through any online brokerage.
Other companies in Pacific Biosciences’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Sotera Health (NASDAQ:SHC).
Pacific Biosciences has a consensus price target of $4.79.
The stock price for Pacific Biosciences (NASDAQ: PACB) is $1.92 last updated December 23, 2024 at 3:30 PM EST.
There are no upcoming dividends for Pacific Biosciences.
Pacific Biosciences’s Q4 earnings are confirmed for Thursday, February 13, 2025.
There is no upcoming split for Pacific Biosciences.
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.